VTCN1 and breast carcinoma: Notably, the B7-H4 protein is highly expressed in several tumors, including breast cancer, in combination with its low or absent protein expression in normal tissues, suggesting that B7-H4 is an attractive immunotherapeutic target for ICI’s [35].